2006Zhongguo yaofangRequires access

Pharmacokinetics of Single Dose Intramuscularly Injected Ziprasidone Mesylate in Healthy Volunteers

Yang Qiumin, Yuanda Zhou

Open publisher page 0 citations

Abstract

OBJECTIVE:To study the pharmacokinetics of a single dose of intramuscularly injected ziprasidone mesylate in healthy volunteers.METHODS:A total of10healthy volunteers were received intramuscularly single dose of ziprasidone me-sylate20mg,venous blood samples were taken at different time after intramuscular injection,the concentrations of ziprasidone in serum were determined by HPLC,and the pharmacokinetic parameters were calculated with3p97program.RESULTS:The concentration-time curves of ziprasidone fitted to two-compartment model.The pharmacokinetic parameters were stated as follows,C max was(866.32±482.88)ng/ml;t max was(0.57±0.23)h,t 1/2ke was(2.17±1.04)h,CL was(17.0±9.00)ml/h,AUC 0~12 was(1467.94±644.80)(ng·h)/ml and ACU 0~∝ was(1603.48±722.47)(ng·h)/ml.CONCLUSIONS:The pharmacoki-netics parameters in10healthy volunteers after intramuscular injection of20mg ziprasidone mesylate are in line with that re-ported in the literature.

About this research paper

What this paper is about

OBJECTIVE:To study the pharmacokinetics of a single dose of intramuscularly injected ziprasidone mesylate in healthy volunteers.METHODS:A total of10healthy volunteers were received intramuscularly single dose of ziprasidone me-sylate20mg,venous blood samples were taken at different time after intramuscular injection,the concentrations of ziprasidone in serum were determined by HPLC,and the pharmacokinetic parameters were calculated with3p97program.RESULTS:The concentration-time curves of ziprasidone fitted to two-compartment model.The pharmacokinetic parameters were stated as follows,C max was(866.32±482.88)ng/ml;t max was(0.57±0.23)h,t 1/2ke was(2.17±1.04)h,CL was(17.0±9.00)ml/h,AUC 0~12 was(1467.94±644.80)(ng·h)/ml and ACU 0~∝ was(1603.48±722.47)(ng·h)/ml.CONCLUSIONS:The pharmacoki-netics parameters in10healthy volunteers after intramuscular injection of20mg ziprasidone mesylate are in line with that re-ported in the literature.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To study the pharmacokinetics of a single dose of intramuscularly injected ziprasidone mesylate in healthy volunteers.METHODS:A total of10healthy volunteers were received intramuscularly single dose of ziprasidone me-sylate20mg,venous blood samples were taken at different time after intramuscular injection,the concentrations of ziprasidone in serum were determined by HPLC,and the pharmacokinetic parameters were calculated with3p97program.RESULTS:The concentration-time curves of ziprasidone fitted to two-compartment model.The pharmacokinetic parameters were stated as follows,C max was(866.32±482.88)ng/ml;t max was(0.57±0.23)h,t 1/2ke was(2.17±1.04)h,CL was(17.0±9.00)ml/h,AUC 0~12 was(1467.94±644.80)(ng·h)/ml and ACU 0~∝ was(1603.48±722.47)(ng·h)/ml.CONCLUSIONS:The pharmacoki-netics parameters in10healthy volunteers after intramuscular injection of20mg ziprasidone mesylate are in line with that re-ported in the literature.

Key concepts: Ziprasidone, Pharmacokinetics, Pharmacology, Mesylate, Chemistry, Serum concentration, Medicine, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics of Single Dose Intramuscularly Injected Ziprasidone Mesylate in Healthy Volunteers — Research Paper | ScholarLens